MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Trinity Biotech plc Company Profile (NASDAQ:TRIB)

Consensus Ratings for Trinity Biotech plc (NASDAQ:TRIB) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $18.00 (63.79% upside)

Analysts' Ratings History for Trinity Biotech plc (NASDAQ:TRIB)
Show:
DateFirmActionRatingPrice TargetActions
4/21/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015Craig HallumDowngradeBuy -> Hold$24.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2015Raymond JamesInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Trinity Biotech plc (NASDAQ:TRIB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
4/19/2016Q1$0.08$0.06ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2016Q4$0.09$0.29$251.00 million$271.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q3$0.09$0.10$25.40 million$27.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q2$0.14$0.07ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$0.17$0.17$25.93 million$25.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414$0.18$0.18$27.30 million$26.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q114$0.20$0.19$27.30 million$27.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q413$0.20$0.18$27.00 million$26.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014$0.19$0.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q4$0.21$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013Q313$0.21$0.21$24.68 million$24.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$0.20$0.21$22.03 million$21.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2013Q4 2012$0.21$0.20$21.84 million$20.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Trinity Biotech plc (NASDAQ:TRIB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.08$0.08$0.08
Q2 20162$0.05$0.07$0.06
Q3 20162$0.07$0.10$0.09
Q4 20162$0.07$0.09$0.08
Q1 20171$0.04$0.04$0.04
Q2 20171$0.06$0.06$0.06
Q3 20171$0.08$0.08$0.08
Q4 20171$0.08$0.08$0.08
(Data provided by Zacks Investment Research)
Dividend History for Trinity Biotech plc (NASDAQ:TRIB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/23/2014annual$0.223.72%6/6/20146/10/20147/1/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Trinity Biotech plc (NASDAQ:TRIB)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Trinity Biotech plc (NASDAQ:TRIB)
DateHeadline
06/27/16 07:46 AMShare Update and Earnings Review for Trinity Biotech plc (NASDAQ:TRIB) - Press Telegraph
06/24/16 06:56 PMTrinity Biotech plc (NASDAQ:TRIB) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 09:27 AMCovering the Bases on Trinity Biotech plc (NASDAQ:TRIB): Where is the Stock Going? - Press Telegraph
06/22/16 06:48 PMThe Top 200 Point-Of-Care Diagnostics Companies Worldwide
06/20/16 06:27 PMTrinity Biotech Plc (NASDAQ:TRIB) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 06:37 PMRecently Issued Stock Ratings For Trinity Biotech Plc (NASDAQ:TRIB) - Fiscal Standard
06/16/16 07:04 PMPoint-of-care Infectious Disease Diagnostics Market : Share, Forecast and Demand 2015 – 2021
06/10/16 07:13 PMTrend Of Rating Given To Trinity Biotech plc (NASDAQ:TRIB) - Investor Newswire
06/09/16 07:26 PMTrinity Biotech plc (NASDAQ:TRIB) Earns Rating Score Of 2 - RealistInvestor.com
06/08/16 10:01 AMTRINITY BIOTECH PLC (NASDAQ:TRIB) Financial Condition Compared to S&P 500 - CML News
06/03/16 09:55 AMShare Rating Focus on Trinity Biotech plc (NASDAQ:TRIB) - HNN
06/02/16 10:07 AMTarget Price and Stock Performance Rundown for Trinity Biotech plc (NASDAQ:TRIB) - HNN - Target Price and Stock Performance Rundown for Trinity Biotech plc (NASDAQ:TRIB)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Trinity Biotech plc (NASDAQ:TRIB ...and more »
06/02/16 10:07 AMTrinity Biotech Plc (NASDAQ:TRIB) Updated Price Targets - FTSE News - Trinity Biotech Plc (NASDAQ:TRIB) Updated Price TargetsFTSE News10/23/2015 – Trinity Biotech plc was downgraded to “hold” by analysts at Craig-Hallum. They now have a USD 14 price target on the stock. 09/03/2015 – Raymond James began new coverage on Trinity Biotech plc giving the company a “outperform” rating.Trinity Biotech Plc (NASDAQ:TRIB) Updated Analyst CoverageRisers & Fallersall 6 news articles »
05/31/16 08:05 AMTrinity Biotech Plc (NASDAQ:TRIB) Broker Price Targets For The Coming Week - Share Trading News - Trinity Biotech Plc (NASDAQ:TRIB) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Trinity Biotech plc (NASDAQ:TRIB). The latest reports which are currently in issue on Monday 30th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...Are Analysts Bearish Trinity Biotech plc (ADR) (NASDAQ:TRIB) After Last Week?HNNall 2 news articles »
05/26/16 12:40 PMTarget Check and Stock Performance Recap Trinity Biotech plc (NASDAQ:TRIB) - Wall Street Hints and News - Target Check and Stock Performance Recap Trinity Biotech plc (NASDAQ:TRIB)Wall Street Hints and NewsTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, Trinity Biotech plc ...and more »
05/26/16 12:40 PMBroker Roundup For Trinity Biotech Plc (NASDAQ:TRIB) - Share Trading News - Broker Roundup For Trinity Biotech Plc (NASDAQ:TRIB)Share Trading News10/29/2013 – Trinity Biotech plc was downgraded to “hold” by analysts at Jefferson Research. The share price of Trinity Biotech plc (NASDAQ:TRIB) was up +0.18% during the last trading session, with a day high of 11.31. 64056 shares were traded on ...
05/25/16 01:35 PMHow Many Trinity Biotech plc (ADR) (NASDAQ:TRIB)'s Analysts Are Bullish? - Wall Street Hints and News - How Many Trinity Biotech plc (ADR) (NASDAQ:TRIB)'s Analysts Are Bullish?Wall Street Hints and NewsOut of 6 analysts covering Trinity Biotech (NASDAQ:TRIB), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. Trinity Biotech has been the topic of 4 analyst reports since July 29, 2015 according to StockzIntelligence Inc. Below ...Could Trinity Biotech plc (ADR) Recover After Today's Huge Decline?Franklin Independentall 2 news articles »
05/20/16 01:46 PMShare Performance and Target Price Review for Trinity Biotech plc (NASDAQ:TRIB) - Wall Street Hints and News - Share Performance and Target Price Review for Trinity Biotech plc (NASDAQ:TRIB)Wall Street Hints and NewsLooking at stock activity from multiple angles may be of benefit when examining share performance. Investors have the ability to focus in on short or long term share performance. During the most recent trading session, Trinity Biotech plc (NASDAQ:TRIB) ...and more »
05/20/16 01:46 PMAnalyst Rating Check on Trinity Biotech plc (NASDAQ:TRIB) - Wall Street Hints and News - Analyst Rating Check on Trinity Biotech plc (NASDAQ:TRIB)Wall Street Hints and NewsCurrently, sell-side analysts have provided a consensus stock rating of 2 on shares of Trinity Biotech plc (NASDAQ:TRIB). Analysts that cover the company will usually offer Buy, Sell, or Hold recommendations based on in-depth research. This consensus ...and more »
05/14/16 07:37 AMConsensus Rating Review for Trinity Biotech plc (NASDAQ:TRIB) - Wall Street Hints and News - Consensus Rating Review for Trinity Biotech plc (NASDAQ:TRIB)Wall Street Hints and NewsEquity research analysts currently have a consensus rating of 2 on shares of Trinity Biotech plc (NASDAQ:TRIB). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, Sell, or ...and more »
05/04/16 12:53 PMTrinity Biotech Plc :TRIB-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/29/16 08:31 AMShare Performance and Target Price Review Trinity Biotech plc (NASDAQ:TRIB) - B.O.D.Y Confidential - Share Performance and Target Price Review Trinity Biotech plc (NASDAQ:TRIB)B.O.D.Y ConfidentialDuring the most recent trading session, shares of Trinity Biotech plc (NASDAQ:TRIB) ended up with a move of -0.58%. Sell-side analysts have given a consensus target price of $17.33 on company shares. Target price projections may differ greatly from one ...and more »
04/27/16 09:17 AMTrinity Biotech plc (NASDAQ:TRIB) Wall Street Rating in Focus - News Tribune - Trinity Biotech plc (NASDAQ:TRIB) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 3 equity research firms that cover shares of Trinity Biotech plc (NASDAQ:TRIB).and more »
04/27/16 09:17 AMTrinity Biotech plc (NASDAQ:TRIB) Share Rating Recap - The Post - Trinity Biotech plc (NASDAQ:TRIB) Share Rating RecapThe PostShares of Trinity Biotech plc (NASDAQ:TRIB) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/19/16 01:04 PMEdited Transcript of TRIB earnings conference call or presentation 19-Apr-16 3:00pm GMT -
04/19/16 10:28 AMTrinity Biotech Announces Q1 2016 Financial Results - [at noodls] - 187afc89-cbb6-4838-b7b1-c3774d374a17.pdf Press Release dated April 19, 2016 Contact: Trinity Biotech plc Lytham Partners LLC Kevin Tansley Joe Diaz, Joe Dorame & Robert Blum (353)-1-2769800 602-889-9700 ...
04/19/16 09:16 AMTracking Earnings for Trinity Biotech plc (NASDAQ:TRIB) - RiversideGazette.com - Tracking Earnings for Trinity Biotech plc (NASDAQ:TRIB)RiversideGazette.comTrinity Biotech plc (NASDAQ:TRIB) has a current consensus EPS estimate for the quarter of $0.08 based on Street analyst predictions. The company is scheduled to next report earnings information on or around 2016-04-19 for the period ending 2016-03-31.and more »
04/19/16 07:35 AM8:35 am Trinity Biotech misses Q1 estimates; answering FDA questions on high sensitivity cardiac Troponin-I assay and Meritas Point-of-Care Analyzer -
04/19/16 07:30 AMTrinity Biotech Announces Results for Q1, 2016 - [GlobeNewswire] - DUBLIN, April 19, 2016-- Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ...
04/19/16 06:07 AMQ1 2016 Trinity Biotech PLC Earnings Release - Time Not Supplied -
04/17/16 07:22 AMTrinity Biotech plc (TRIB) Scheduled to Post Quarterly Earnings on Tues.. Las Vegas Blog - Trinity Biotech plc (NASDAQ:TRIB) will concern its quarterly earnings knowledge on Tues., Apr. 19th. Analysts anticipate the company to announce earnings of $zero.08 per share for the quarter. Trinity Biotech plc (NASDAQ:TRIB) last issued its earnings ...
04/15/16 11:49 AMTrinity Biotech : to Announce Q1 2016 Financial Results - Conference Call Scheduled for April 19, 2016 at 11:00 am EASTERN DUBLIN - April 15, 2016 - Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report ...
04/15/16 06:15 AMTrinity Biotech to Announce Q1 2016 Financial Results - [at noodls] - 3a42bab7-990f-4626-8e43-b8d7bfcc0d53.pdf Press Release dated April 15, 2016 Contact: Trinity Biotech plc Lytham Partners LLC Kevin Tansley Joe Diaz, Joe Dorame & Robert Blum (353)-1-2769800 602-889-9700 ...
04/13/16 01:50 PMTrinity Biotech plc (NASDAQ:TRIB): Quick Look at Earnings - News Tribune - Trinity Biotech plc (NASDAQ:TRIB): Quick Look at EarningsNews TribuneWhen Trinity Biotech plc (NASDAQ:TRIB) issues their next quarterly report on or near 2016-05-05, Wall Street analysts are predicting they will report earnings per share of $0.08. This consensus EPS number is provided by Zacks Research, which might ...and more »
04/13/16 01:50 PMTrinity Biotech plc (NASDAQ:TRIB) Analyst Recommendation Outlook - Clinton Financial - Trinity Biotech plc (NASDAQ:TRIB) Analyst Recommendation OutlookClinton FinancialCovering analysts usually give Buy, Sell and Hold recommendations along with guidance and company earnings estimates. There are 3 analysts providing ratings for Trinity Biotech plc (NASDAQ:TRIB). 1 have given the stock a “Strong Buy”, 1 rate it a “Buy ...and more »
04/13/16 12:59 PMTRINITY BIOTECH PLC Financials -
04/12/16 11:49 AMEarnings Watch on Trinity Biotech plc (NASDAQ:TRIB) - RiversideGazette.com - Earnings Watch on Trinity Biotech plc (NASDAQ:TRIB)RiversideGazette.comTrinity Biotech plc (NASDAQ:TRIB) has a consensus earnings per share estimate for the current quarter of $0.08 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-05-05 for the period ending ...and more »
04/09/16 11:10 AMAnalyst Ratings Check Trinity Biotech plc (NASDAQ:TRIB) - Business Standard Tribune - Analyst Ratings Check Trinity Biotech plc (NASDAQ:TRIB)Business Standard TribuneCovering sell-side analysts have an average rating of 2 on shares of Trinity Biotech plc (NASDAQ:TRIB). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating lands on a 1 to 5 scale. A 1 or ...and more »
04/09/16 11:10 AMWere Analysts Bearish Trinity Biotech plc (ADR) (NASDAQ:TRIB) This Week? - RiversideGazette.com - Were Analysts Bearish Trinity Biotech plc (ADR) (NASDAQ:TRIB) This Week?RiversideGazette.comOut of 6 analysts covering Trinity Biotech (NASDAQ:TRIB), 6 rate it “Buy”, 0 “Sell”, while 1 “Hold”. This means 86% are positive. Trinity Biotech was the topic in 4 analyst reports since July 29, 2015 according to StockzIntelligence Inc. Below is a ...Analysts Set Trinity Biotech plc (NASDAQ:TRIB) PT at $17.00Web Breaking NewsNew Analyst Ratings On Trinity Biotech Plc (NASDAQ:TRIB)Risers & Fallersall 3 news articles »
04/07/16 12:20 PMNew Analyst Ratings On Trinity Biotech Plc (NASDAQ:TRIB) - Risers & Fallers - New Analyst Ratings On Trinity Biotech Plc (NASDAQ:TRIB)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Trinity Biotech plc (NASDAQ:TRIB). The latest broker reports which are currently outstanding on Thursday 7th of April state 2 analysts have a rating of “strong buy”, 4 ...
04/06/16 01:57 PMTime to Sell Trinity Biotech plc (ADR) After Today's Gap Down? - Clinton Financial - Time to Sell Trinity Biotech plc (ADR) After Today's Gap Down?Clinton FinancialThe stock of Trinity Biotech plc (ADR) (NASDAQ:TRIB) gapped down by $0.03 today and has $9.81 target or 11.00% below today's $11.02 share price. The 8 months technical chart setup indicates high risk for the $253.90 million company. The gap down was ...
04/05/16 01:21 PMNext Weeks Broker Price Targets For Trinity Biotech Plc (NASDAQ:TRIB) - Share Trading News - Next Weeks Broker Price Targets For Trinity Biotech Plc (NASDAQ:TRIB)Share Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Trinity Biotech plc (NASDAQ:TRIB). The most recent broker reports which have been released note that 2 analysts have ...and more »
04/05/16 01:21 PMEarnings View for Trinity Biotech plc (NASDAQ:TRIB) - RiversideGazette.com - Earnings View for Trinity Biotech plc (NASDAQ:TRIB)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $0.08 on shares of Trinity Biotech plc (NASDAQ:TRIB). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released on or around 2016-05-05 ...and more »
04/02/16 11:57 AMAverage Rating Watch Trinity Biotech plc (NASDAQ:TRIB) - Business Standard Tribune - Average Rating Watch Trinity Biotech plc (NASDAQ:TRIB)Business Standard TribuneStreet analysts that cover Trinity Biotech plc (NASDAQ:TRIB) presently have an average broker rating of 2 on the stock. This average rating comes from Zacks Research compiling polled analyst ratings taken into consideration. The average rating falls on ...and more »
04/01/16 01:41 PMShould Investors Buy Trinity Biotech plc (NASDAQ:TRIB)? - Clinton Financial - Should Investors Buy Trinity Biotech plc (NASDAQ:TRIB)?Clinton FinancialOut of the 3 analysts covering shares of Trinity Biotech plc (NASDAQ:TRIB), 1 rate it a “Strong Buy”, 1 rate it a “Buy”, 1 are advising to Hold the shares and 0 are saying “Sell”. Each recommendation can be mapped to an integer using a 1 to 5 scale ...and more »
04/01/16 01:41 PMTrinity Biotech Plc (NASDAQ:TRIB) Latest Broker Views - Risers & Fallers - Trinity Biotech Plc (NASDAQ:TRIB) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Trinity Biotech plc (NASDAQ:TRIB). According to the latest broker reports outstanding on Thursday 31st of March, 2 analysts have a rating of “strong buy”, 4 analysts ...
03/30/16 01:08 PMEarnings Outlook on Trinity Biotech plc (NASDAQ:TRIB) - RiversideGazette.com - Earnings Outlook on Trinity Biotech plc (NASDAQ:TRIB)RiversideGazette.comAnalysts and investors will be looking forward to the next earnings release from Trinity Biotech plc (NASDAQ:TRIB) which is scheduled to be on or around 2016-05-05 for the period ending 2016-03-31. Covering sell-side analysts have a current quarter ...and more »
02/26/16 09:06 AMTrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2015 Financial Results - [GlobeNewswire] - DUBLIN, Feb. 26, 2016-- Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth ...
12/28/15 06:47 AMBarron's Recap: The New King Of Video -
12/17/15 07:36 AMTrinity Biotech Announces Q3 2015 Financial Results - [at noodls] - 144cd4d2-f717-4e9c-b9c4-5528f807b502.pdf Press Release dated October 22, 2015 Contact: Trinity Biotech plc Lytham Partners LLC Kevin Tansley Joe Diaz, Joe Dorame & Robert Blum (353)-1-2769800 602-889-9700 ...
About Trinity Biotech plc

Trinity Biotech plc logoTrinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Trinity Biotech also is a provider of raw materials to the life sciences and research industries globally. Trinity Biotech markets its portfolio of almost 850 products to customers in approximately 100 countries around the world. The primary market for Trinity Biotech's diagnostic products is the Americas (which consists principally of North America and South America). Its products are classified as point-of-care, emergency medicine, clinical laboratory and blood bank screening. The Company markets products under Uni-Gold, Recombigen, Meritas, Captia, MicroTrak, Bartels, MarDx, MarBlot, Premier, Ultra2, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TRIB
  • CUSIP:
Key Metrics:
  • Previous Close: $10.99
  • 50 Day Moving Average: $11.13
  • 200 Day Moving Average: $11.02
  • P/E Ratio: 41.16
  • P/E Growth: 3.10
  • Market Cap: $255.92M
  • Current Quarter EPS Consensus Estimate: $0.21 EPS
Additional Links:
Trinity Biotech plc (NASDAQ:TRIB) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha